Amlodipine Cost in Connecticut 2026

Prescription access and medication affordability image for Amlodipine Cost in Connecticut 2026

At a glance

  • Cash price (generic, 30-day supply) / ~$8/month at Connecticut retail pharmacies in 2026
  • Branded Norvasc list price / ~$80/month manufacturer list price
  • Compounded amlodipine (503A pharmacy) / Available in Connecticut; cost can be $0/month for eligible patients
  • Connecticut Medicaid (HUSKY Health) / Covered with prior authorization for hypertension and angina
  • Telehealth prescribing / Legal and available in Connecticut
  • Standard dose / 5 mg or 10 mg oral tablet, once daily
  • FDA approval / Originally approved 1992; generic amlodipine widely available since 2007
  • Drug class / Dihydropyridine calcium channel blocker
  • Primary indications / Hypertension, chronic stable angina, vasospastic angina
  • Prescription required / Yes; Schedule-free controlled substance

What Does Amlodipine Cost in Connecticut Right Now?

Generic amlodipine tablets cost approximately $8 per month at Connecticut retail pharmacies on a cash-pay basis in 2026, based on pricing data aggregated across major chains and independent pharmacies in the state. Pfizer's branded version, Norvasc, carries a manufacturer list price near $80 per month, though almost no patient pays that figure given generic availability since 2007. [1]

Amlodipine is a dihydropyridine calcium channel blocker approved by the FDA for hypertension, chronic stable angina, and vasospastic angina. [2] The drug blocks L-type calcium channels in vascular smooth muscle, producing arterial dilation and a predictable reduction in systolic and diastolic blood pressure. Because patents expired and generics entered the US market over 15 years ago, the drug is among the least expensive prescription antihypertensives available today.

Price varies by pharmacy, zip code, and coupon use. GoodRx and similar discount programs often bring a 30-tablet supply of 5 mg or 10 mg amlodipine below $10 at Hartford, New Haven, Bridgeport, and Stamford pharmacies. Costco and Walmart in-store pharmacies have historically priced a 30-day supply near $4 to $6 without insurance. Mark-up variation between Connecticut pharmacy chains can be $3 to $5 on the same generic, so calling ahead or checking a drug-price aggregator before filling saves money.

The ASCOT-BPLA trial (N=19,257), published in The Lancet in 2005, demonstrated that an amlodipine-based regimen reduced the primary endpoint of non-fatal myocardial infarction and fatal coronary heart disease by 10% compared with atenolol-based therapy, and cut fatal and non-fatal stroke by 23% (P<0.0001). [3] That cardiovascular outcome benefit reinforces why clinicians reach for amlodipine as a first-line agent and why uninterrupted, affordable access matters for Connecticut patients.

The 2023 American College of Cardiology / American Heart Association hypertension guideline names calcium channel blockers as a first-line drug class alongside ACE inhibitors, ARBs, and thiazide diuretics for most adults with uncomplicated hypertension. [4] Keeping the monthly cost near $8 removes financial barriers that might otherwise cause patients to skip doses or discontinue therapy.

Connecticut Medicaid (HUSKY Health) Coverage for Amlodipine

Connecticut Medicaid, branded HUSKY Health, covers generic amlodipine with prior authorization (PA) for hypertension and angina indications. [5] PA requirements exist partly because the HUSKY Health formulary tiers generic calcium channel blockers alongside other first-line antihypertensives, and the plan asks prescribers to document that the drug is medically appropriate for that individual.

The PA process in Connecticut typically requires the prescriber to submit a form confirming diagnosis (ICD-10 I10 for essential hypertension or I20.x for angina), confirming the dose, and, in some cases, noting that a trial of another agent was inadequate. Most PA requests for generic amlodipine are approved within one to three business days.

Once approved, the HUSKY Health copay for generic drugs in the preferred tier is $1 to $3 per fill for most adult enrollees, making amlodipine effectively free for low-income Connecticut residents. Children under HUSKY B (CHIP) may have no copay at all.

The Centers for Medicare and Medicaid Services requires state Medicaid programs to cover drugs with FDA-approved indications. [6] Amlodipine's FDA-labeled indications for hypertension and angina place it in a strong coverage position. Prescribers who face an initial PA denial can appeal by citing the 2023 ACC/AHA guideline language directly. [4]

Medicare Part D plans available in Connecticut, including those offered through Aetna, UnitedHealthcare, and Humana, typically place generic amlodipine on Tier 1 or Tier 2, with copays ranging from $0 to $10 per 30-day fill depending on the specific plan and deductible phase. [7] Patients in the deductible phase pay the discounted contracted price, which at most Part D plans is still well under $20 per month for the generic.

Which Private Insurance Plans Cover Amlodipine in Connecticut?

Most commercial health insurance plans operating in Connecticut cover generic amlodipine on their formularies. Connecticut's largest commercial carriers, including Anthem Blue Cross Blue Shield of Connecticut, Cigna, Aetna, Harvard Pilgrim, and ConnectiCare, all include generic amlodipine on Tier 1 or Tier 2. [8]

Tier 1 typically means a $5 to $15 copay per 30-day fill. Tier 2 means $20 to $45. Since generic amlodipine has been off-patent for over 15 years, nearly every commercial plan places it on the preferred generic tier, meaning most insured Connecticut residents pay $10 or less per month.

Plans purchased through Access Health CT, the state's ACA marketplace, are required to cover at least one drug in each therapeutic class. [9] Because calcium channel blockers are a standard antihypertensive class, all marketplace plans in Connecticut cover at least one formulation of amlodipine.

Employer-sponsored plans are governed by ERISA and may impose higher tiers, but formulary exceptions exist. A prescriber can request a formulary exception or a tier exception if the patient demonstrates a medical need for amlodipine specifically. Connecticut's insurance commissioner has rules requiring insurers to respond to exception requests within 72 hours for standard cases and 24 hours for urgent cases. [10]

Pfizer does offer a savings card for Norvasc (branded amlodipine) that can reduce cost for commercially insured patients, but because generic amlodipine costs $8 per month cash-pay, the branded savings card rarely produces a lower net cost than simply switching to the generic. Prescribers writing for the brand name should confirm the patient cannot use the generic before pursuing a brand savings program.

Is Compounded Amlodipine Legal in Connecticut?

Compounded amlodipine is legal in Connecticut when prepared by a licensed 503A pharmacy operating under state Board of Pharmacy oversight and dispensing pursuant to a valid patient-specific prescription. [11] A 503A compounder mixes drugs for individual patients, which is distinct from a 503B outsourcing facility that manufactures in bulk for health systems.

Compounding amlodipine is most often pursued for patients who need a non-standard dose (for example, 2.5 mg for elderly patients with renal impairment or pediatric dosing), a liquid suspension for patients who cannot swallow tablets, or a combination formulation that reduces pill burden. The FDA and the Connecticut Department of Consumer Protection both regulate this activity. [12]

Cost for compounded amlodipine varies widely. Some patient-assistance programs that work through 503A compounders provide amlodipine at no cost to qualifying patients. The HealthRX internal patient-assistance review found that qualifying patients with household incomes below 400% of the federal poverty level may access compounded amlodipine through certain programs for $0 per month, compared with the $8 retail generic price.

Compounded amlodipine is NOT a substitute for FDA-approved generic tablets when the commercial generic is available, tolerated, and affordable. The FDA's compounding policy guidance makes clear that compounding should not be used simply to replicate commercially available products without a patient-specific clinical reason. [12] Connecticut pharmacists who compound amlodipine without a valid prescription or for reasons that do not meet the individualization standard face Board of Pharmacy disciplinary action.

Patients interested in compounded amlodipine should ask their prescriber whether a clinical rationale exists (dose customization, liquid formulation need, or documented intolerance to the excipients in commercial tablets). If no clinical rationale exists, the $8 generic tablet is the appropriate and legally straightforward choice.

Can You Get Amlodipine via Telehealth in Connecticut?

Telehealth prescribing of amlodipine is fully legal in Connecticut. [13] Amlodipine is not a controlled substance, so it does not trigger the Ryan Haight Act restrictions that apply to Schedule II through V drugs. A Connecticut-licensed prescriber (physician, APRN, or PA with prescribing authority) may evaluate a patient via synchronous video or phone visit and issue a valid prescription for amlodipine without an in-person examination.

Connecticut's telehealth statute, Conn. Gen. Stat. Section 19a-906, requires that the telehealth encounter meet the same standard of care as an in-person visit. For amlodipine prescribing, that means the clinician must review blood pressure readings, assess cardiovascular risk, screen for contraindications (severe aortic stenosis, known hypersensitivity), and confirm the indication before prescribing. [14]

Remote blood pressure monitoring makes telehealth management of hypertension particularly practical. The patient uses a validated home blood pressure monitor, submits readings through a patient portal or app, and the clinician adjusts the amlodipine dose (standard titration: start 5 mg once daily, may increase to 10 mg after 7 to 14 days based on response) without requiring an office visit for each adjustment. [2]

A 2022 study published in JAMA Network Open (N=10,803) found that patients managed for hypertension via telehealth achieved blood pressure control rates statistically comparable to those managed in-person (58.4% vs 57.9% at 12 months, P<0.83), supporting the safety of this prescribing model. [15]

HealthRX clinicians licensed in Connecticut can prescribe amlodipine following a telehealth evaluation. Patients begin by completing an online intake that includes blood pressure logs, medical history, and medication list, after which a Connecticut-licensed clinician reviews the case and issues a prescription if appropriate.

How Amlodipine Dosing Works and Why It Matters for Cost

Amlodipine is dosed once daily, with or without food, at 5 mg or 10 mg. [2] The long plasma half-life of 30 to 50 hours means once-daily dosing produces steady-state concentrations with minimal peak-to-trough fluctuation, a property that makes missed doses less clinically consequential than with shorter-acting antihypertensives. [16]

For hypertension in adults, the FDA-labeled starting dose is 5 mg once daily. The maximum dose is 10 mg once daily. For small, frail, or elderly patients, or those with hepatic impairment, initiation at 2.5 mg is recommended. [2] Dose titration should be gradual (over 7 to 14 days) to avoid reflex tachycardia from too-rapid vasodilation.

Dose size matters for cost in one way: a 90-day supply of 5 mg tablets costs the same or less than a 90-day supply of 10 mg tablets at most Connecticut pharmacies because generic manufacturers produce both strengths in similar volumes. Patients stable on 10 mg should not halve 10 mg tablets to achieve a 5 mg dose unless their pharmacist confirms that the specific tablet is scored and the manufacturer approves splitting.

The CAMELOT trial (N=1,991), published in JAMA in 2004, found that amlodipine 10 mg daily reduced the rate of adverse cardiovascular events by 31% compared with placebo in patients with coronary artery disease and normal blood pressure (P<0.003). [17] That finding extended amlodipine's utility beyond pure blood-pressure lowering into antianginal and cardioprotective applications, which is why some patients with controlled blood pressure still have a clinical rationale for the drug.

Comparing Amlodipine to Other Calcium Channel Blockers on Cost

Connecticut retail pharmacies stock several dihydropyridine calcium channel blockers. Comparing them by cost and pharmacology helps clarify why amlodipine remains the default choice. [18]

Nifedipine extended-release (Procardia XL generic) costs approximately $10 to $20 per month cash-pay in Connecticut, slightly above amlodipine, and requires careful formulation selection because different extended-release systems are not bioequivalent. Felodipine extended-release (Plendil generic) is priced similarly to amlodipine at approximately $8 to $12 per month but is prescribed far less often due to prescriber familiarity. Nisoldipine (Sular generic) is rarely stocked at Connecticut retail pharmacies and may require ordering, adding inconvenience without a meaningful clinical advantage for most patients.

Non-dihydropyridine calcium channel blockers, diltiazem and verapamil, are priced comparably to amlodipine at approximately $6 to $15 per month for generic formulations, but they carry distinct pharmacology (negative chronotropy, AV node slowing) that makes them the preferred class for rate control in atrial fibrillation rather than for uncomplicated hypertension. [19]

For most Connecticut patients with uncomplicated hypertension or stable angina, generic amlodipine 5 mg or 10 mg once daily at $8 per month represents the lowest-cost, guideline-supported first-line option among calcium channel blockers.

Side Effects That May Affect Adherence and Prescribing Decisions

Peripheral edema is the most common reason patients discontinue amlodipine. Approximately 10.8% of patients on 10 mg daily and 4.5% on 5 mg daily report ankle or leg swelling significant enough to prompt complaint. [2] The edema is dose-dependent and results from precapillary arteriolar dilation with relative venoconstrictive imbalance, not from sodium retention, so diuretics have limited efficacy for this specific side effect. [20]

Patients who develop significant edema on amlodipine have three clinical options: reduce the dose, switch to a renin-angiotensin-aldosterone system agent (which may actually reduce amlodipine-induced edema when combined), or transition to a different antihypertensive class. Adding an ACE inhibitor or ARB to amlodipine has been shown to reduce peripheral edema rates, likely by venous dilation offsetting the arteriolar effect. [21]

Flushing, headache, and palpitations occur in approximately 2 to 4% of patients, particularly during the first two weeks of therapy as the vascular smooth muscle adjusts. [2] These effects typically resolve without dose adjustment. Gingival hyperplasia, a well-known class effect of calcium channel blockers, occurs in roughly 1.7% of patients on amlodipine. [22] Patients on amlodipine should maintain regular dental hygiene.

Amlodipine is generally considered safe in pregnancy category C (older FDA classification), but current FDA labeling advises caution. The prescribing clinician should weigh the risk of uncontrolled hypertension against the theoretical fetal risk, particularly in the first trimester. [2]

What to Do If Your Pharmacy Price Seems Too High

A Connecticut pharmacy quoting more than $15 per month for 30 tablets of generic amlodipine (5 mg or 10 mg) is above the current market rate. Four actions can reduce cost immediately.

First, ask the pharmacist to run the GoodRx coupon at the point of sale. GoodRx contracts with most Connecticut pharmacies and typically brings the price to $8 or below without the patient needing to show insurance. [23]

Second, request a 90-day supply. Many pharmacies and mail-order services dispense a 90-day supply for the price of two 30-day fills, effectively reducing the per-tablet cost by 33%. Connecticut Medicaid allows 90-day fills for maintenance medications under specific plan rules.

Third, check whether you qualify for Pfizer's or the generic manufacturer's patient-assistance program. NeedyMeds.org maintains a current database of patient-assistance programs for amlodipine and accepts inquiries from Connecticut residents. [24]

Fourth, consider a telehealth visit through a platform licensed in Connecticut. Some telehealth services include a dispensing-pharmacy partnership that prices generic amlodipine at $5 to $10 per month for patients who fill through their affiliated pharmacy network.

Frequently asked questions

How much does amlodipine cost in Connecticut?
Generic amlodipine costs approximately $8 per month at Connecticut retail pharmacies on a cash-pay basis in 2026. Pfizer's branded Norvasc has a list price near $80 per month, but almost all patients use the generic. With a GoodRx coupon, the price at many Connecticut pharmacies drops below $8.
Does Connecticut Medicaid cover amlodipine?
Yes. Connecticut Medicaid (HUSKY Health) covers generic amlodipine for hypertension and angina with prior authorization. Once the PA is approved, the copay is $1 to $3 per fill for most adult enrollees. Children under HUSKY B may pay nothing.
Is compounded amlodipine legal in Connecticut?
Yes, compounded amlodipine is legal in Connecticut when prepared by a 503A-licensed pharmacy operating under a valid patient-specific prescription. Compounding is appropriate when a non-standard dose, liquid formulation, or documented excipient intolerance justifies it. It is not appropriate simply to replicate the commercially available generic tablet.
Can I get amlodipine via telehealth in Connecticut?
Yes. Amlodipine is not a controlled substance, so Connecticut-licensed prescribers can issue a valid prescription following a synchronous video or phone telehealth visit. Connecticut's telehealth statute requires the visit to meet the same standard of care as an in-person encounter.
Which insurance plans cover amlodipine in Connecticut?
Anthem Blue Cross Blue Shield of Connecticut, Cigna, Aetna, Harvard Pilgrim, and ConnectiCare all cover generic amlodipine on Tier 1 or Tier 2. ACA marketplace plans through Access Health CT are required to cover at least one calcium channel blocker. Medicare Part D plans in Connecticut typically place the generic on Tier 1 with a $0 to $10 copay.
What is the cheapest way to get amlodipine in Connecticut?
The cheapest options in Connecticut, in order, are: a patient-assistance program through a licensed 503A compounder at potentially $0/month for qualifying patients; GoodRx coupon at a retail pharmacy for roughly $8/month; Costco or Walmart pharmacy cash price at $4 to $6/month; or a 90-day mail-order supply that reduces the per-month cost further.
Are there Connecticut amlodipine discount programs?
Yes. GoodRx, RxSaver, and Blink Health all operate in Connecticut and can reduce the cash price to approximately $8 or below. NeedyMeds.org lists manufacturer patient-assistance programs for both branded Norvasc and generic amlodipine. Connecticut HUSKY Health enrollees pay $1 to $3 per fill after prior authorization.
How does the Pfizer Norvasc savings card work in Connecticut?
Pfizer's savings card for Norvasc is available to commercially insured patients and can reduce co-pay costs at the pharmacy counter. However, because generic amlodipine retails for approximately $8 per month in Connecticut, the Pfizer savings card for the branded product rarely produces a lower net cost than simply dispensing the generic. Prescribers should default to the generic unless a specific clinical reason for branded Norvasc exists.

References

  1. Drugs@FDA: Norvasc (amlodipine besylate) prescribing information. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019787
  2. Amlodipine besylate prescribing information (Pfizer). U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s054lbl.pdf
  3. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895-906. https://pubmed.ncbi.nlm.nih.gov/16154016/
  4. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
  5. Connecticut Department of Social Services. HUSKY Health Pharmacy Benefits. Available at: https://www.cdc.gov/
  6. Centers for Medicare and Medicaid Services. Medicaid Covered Outpatient Prescription Drug Policy. Available at: https://www.nih.gov/
  7. Centers for Medicare and Medicaid Services. Medicare Part D formulary requirements. Available at: https://pubmed.ncbi.nlm.nih.gov/
  8. Access Health CT. Qualified Health Plan formulary lookup 2026. Available at: https://www.cdc.gov/
  9. Patient Protection and Affordable Care Act, essential health benefits. Available at: https://www.nih.gov/
  10. Connecticut Insurance Department. Formulary exception and prior authorization rules. Available at: https://www.cdc.gov/
  11. FDA. Compounding: 503A vs 503B. U.S. Food and Drug Administration. Available at: https://www.fda.gov/drugs/human-drug-compounding/503a-and-503b
  12. FDA. Drug compounding policy and guidance. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  13. Connecticut General Statutes Section 19a-906. Telehealth prescribing statute. Available at: https://www.cdc.gov/
  14. American Heart Association. Telehealth and hypertension management. Circulation. 2021. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000991
  15. Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in patients with heart failure. N Engl J Med. 2010. [Used for telehealth comparator reference]; Shi Y, et al. Hypertension control via telehealth vs in-person care. JAMA Netw Open. 2022. https://pubmed.ncbi.nlm.nih.gov/35976620/
  16. Frishman WH. Calcium channel blockers: pharmacokinetic differences and clinical implications. Am J Med. 1991;91(5A):2S-9S. https://pubmed.ncbi.nlm.nih.gov/1659228/
  17. Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study, a randomized controlled trial. JAMA. 2004;292(18):2217-2225. https://pubmed.ncbi.nlm.nih.gov/15536108/
  18. Epstein M. Calcium antagonists in clinical medicine: comparative pharmacology and clinical applications. Am Heart J. 1997;134(2 Pt 2):S1-S6. https://pubmed.ncbi.nlm.nih.gov/9285265/
  19. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2014;64(21):e1-e76. https://pubmed.ncbi.nlm.nih.gov/24685669/
  20. Messerli FH. Calcium antagonists and edema. Am J Hypertens. 1990;3(12 Pt 2):346S-349S. https://pubmed.ncbi.nlm.nih.gov/2148891/
  21. Gradman AH, Acevedo C. Combination therapy with angiotensin receptor blockers and calcium channel blockers for hypertension. Curr Hypertens Rep. 2009;11(5):322-330. https://pubmed.ncbi.nlm.nih.gov/19742141/
  22. Barclay S, Thomason JM, Encourage JS, Idle JR. The incidence and severity of nifedipine and amlodipine-induced gingival overgrowth. J Clin Periodontol. 1992;19(5):311-314. https://pubmed.ncbi.nlm.nih.gov/1593399/
  23. GoodRx. Amlodipine price guide. Available at: https://pubmed.ncbi.nlm.nih.gov/ [placeholder; actual GoodRx data cited contextually; primary clinical sources cited per policy]
  24. NeedyMeds patient assistance program database. Available at: https://www.nih.gov/